| The 505 (b)(2) drug approval pathway JJ Darrow, M He, K Stefanini Food and Drug Law Journal 74 (3), 403-439, 2019 | 12 | 2019 |
| Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: An evaluation of Food and Drug Administration flexibilities JJ Darrow, M Najafzadeh, K Stefanini, AS Kesselheim The Lancet Infectious Diseases 20 (7), e159-e164, 2020 | 6 | 2020 |
| Determining which of several simultaneously administered vaccines increase risk of an adverse event SV Wang, K Stefanini, E Lewis, SR Newcomer, B Fireman, MF Daley, ... Drug safety 43, 1057-1065, 2020 | 4 | 2020 |
| Racial and ethnic differences in hospital admissions of emergency department COVID-19 patients J Longcoy, R Patwari, S Hasler, T Johnson, E Avery, K Stefanini, S Suzuki, ... Medical Care 60 (6), 415-422, 2022 | 3 | 2022 |
| The impact of language on hospital outcomes for COVID-19 patients: a study of non-English speaking Hispanic patients S Lopez, J Longcoy, E Avery, Z Isgor, A Jeevananthan, J Perez, B Perez, ... Journal of Racial and Ethnic Health Disparities, 1-7, 2023 | 2 | 2023 |
| Personal history of febrile seizure increases risk of measles-mumps-rubella vaccine attributable seizure SV Wang, L Bessette, K Stefanini, B Fireman, N Lewis, J Duffy, M McNeill, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 521-521, 2020 | | 2020 |
| Determining which of several concomitantly administered vaccines increase risk of an adverse event SV Wang, K Stefanini, E Lewis, SR Newcomer, B Fireman, MF Daley, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 170-171, 2018 | | 2018 |
| DANIEL KOSHY, KRISTINA STEFANINI, ROHAN JA TOMS III, S ESPOSITO | | |
